Skip to content

Feasibility of Cocooning Immunization Strategy With Influenza Vaccine

Prevention of Influenza in Infants by Immunization of Their Contacts in the Household

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00570037
Acronym
Piiitch
Enrollment
544
Registered
2007-12-10
Start date
2007-10-31
Completion date
2008-04-30
Last updated
2013-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Keywords

Influenza, Vaccine, Children

Brief summary

Influenza causes epidemics of respiratory infection in young children each winter. Young children, particularly those under 6 months of age are most vulnerable to suffering from complications secondary to influenza infection. Consequently, influenza vaccine has been recommended for children 6-59 months of age. Influenza vaccine is not approved for use in children under 6 month of age who are at highest risk. Therefore, the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices has recommended vaccination of household contacts of children under 6 month of age - a cocooning strategy. The current study is a hospital-based study to assess the effectiveness of a program to vaccinate birth mothers and household contacts of newborns with influenza vaccine. We propose to study both birth mothers and household contacts of newborns delivered at Durham Regional Hospital and Duke University Medical Center, birthing hospitals serving Durham and surrounding counties in central North Carolina. We will implement several strategies to increase vaccine coverage rates at Durham Regional Hospital utilizing Duke University Hospital as a comparison setting. Strategies will include: standing vaccine orders for birth mothers, vaccine reminders for household contacts, and a hospital based influenza vaccine clinic to increase vaccine accessibility for household contacts. Vaccine coverage rates will be assessed utilizing a survey method (maternal interview at the birthing hospital and a follow-up telephone contact 6-8 weeks later). We hypothesize that influenza vaccine coverage rates for new mothers and household contacts of newborns delivered at the intervention hospital will be higher when compared to coverage rates in the comparison hospital. Demographic determinants of vaccine coverage and reasons for refusal of influenza vaccine will also be assessed.

Interventions

BIOLOGICALTrivalent inactivated influenza vaccine

Intramuscular injection, 0.5 mL or 0.25 mL depending on age of vaccine recipient, one or two doses administered a month apart depending on age and prior influenza vaccination history of recipient

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
Duke University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Mother of a newborn delivered at either Durham Regional Hospital or Duke University Hospital between October 2007 and February 2008

Exclusion criteria

* Fetal demise or stillbirth * Maternal rights relinquished * Language barrier

Design outcomes

Primary

MeasureTime frameDescription
Influenza Vaccine Coverage (Percent) for New Mothers of NewbornsPregnancy period through 6 to 8 weeks postpartumThe percent of new mothers delivering at the hospital who reported receiving an influenza vaccine during their pregnancy, in the hospital after delivery, or during the 6 to 8 week postpartum period
Influenza Vaccine Coverage (Percent) for New Fathers of NewbornsPregnancy period through 6 to 8 weeks postpartumThe percent of new fathers who as reported by new mothers received an influenza vaccine during the mothers pregnancy, in the hospital after delivery, or during the 6 to 8 week period following the birth of their baby
Influenza Vaccine Coverage (Percent) for All Household Contacts of NewbornsPregnancy period through 6 to 8 weeks postpartumThe percent of all household contacts of newborns who as reported by new mothers received an influenza vaccine during the mothers pregnancy, in the hospital after delivery, or during the 6 to 8 week period following the birth of their baby

Countries

United States

Participant flow

Recruitment details

October 2007 through February 2008 Post partum units of two Durham, North Carolina hospitals

Participants by arm

ArmCount
Hospital With Immunization Program238
Hospital With No Immunization Program306
Total544

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyCould not reach for 6-8 week contact4469

Baseline characteristics

CharacteristicHospital With Immunization ProgramHospital With No Immunization ProgramTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
238 Participants306 Participants544 Participants
Region of Enrollment
United States
238 participants306 participants544 participants
Sex: Female, Male
Female
238 Participants306 Participants544 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 2380 / 306

Outcome results

Primary

Influenza Vaccine Coverage (Percent) for All Household Contacts of Newborns

The percent of all household contacts of newborns who as reported by new mothers received an influenza vaccine during the mothers pregnancy, in the hospital after delivery, or during the 6 to 8 week period following the birth of their baby

Time frame: Pregnancy period through 6 to 8 weeks postpartum

ArmMeasureValue (NUMBER)
Hospital With Immunization ProgramInfluenza Vaccine Coverage (Percent) for All Household Contacts of Newborns55 Percentage of All Household Contacts
Hospital With No Immunization ProgramInfluenza Vaccine Coverage (Percent) for All Household Contacts of Newborns39 Percentage of All Household Contacts
Primary

Influenza Vaccine Coverage (Percent) for New Fathers of Newborns

The percent of new fathers who as reported by new mothers received an influenza vaccine during the mothers pregnancy, in the hospital after delivery, or during the 6 to 8 week period following the birth of their baby

Time frame: Pregnancy period through 6 to 8 weeks postpartum

ArmMeasureValue (NUMBER)
Hospital With Immunization ProgramInfluenza Vaccine Coverage (Percent) for New Fathers of Newborns53 Percentage of Fathers of Newborns
Hospital With No Immunization ProgramInfluenza Vaccine Coverage (Percent) for New Fathers of Newborns26 Percentage of Fathers of Newborns
Primary

Influenza Vaccine Coverage (Percent) for New Mothers of Newborns

The percent of new mothers delivering at the hospital who reported receiving an influenza vaccine during their pregnancy, in the hospital after delivery, or during the 6 to 8 week postpartum period

Time frame: Pregnancy period through 6 to 8 weeks postpartum

ArmMeasureValue (NUMBER)
Hospital With Immunization ProgramInfluenza Vaccine Coverage (Percent) for New Mothers of Newborns70 Percentage of Participants
Hospital With No Immunization ProgramInfluenza Vaccine Coverage (Percent) for New Mothers of Newborns64 Percentage of Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026